BlackRock’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$308M Sell
5,779,412
-475,612
-8% -$25.4M 0.01% 1341
2025
Q1
$253M Buy
6,255,024
+330,841
+6% +$13.4M 0.01% 1453
2024
Q4
$165M Buy
5,924,183
+176,393
+3% +$4.91M ﹤0.01% 1762
2024
Q3
$165M Buy
5,747,790
+161,153
+3% +$4.62M ﹤0.01% 1762
2024
Q2
$131M Buy
5,586,637
+694,021
+14% +$16.3M ﹤0.01% 1857
2024
Q1
$124M Buy
4,892,616
+712,109
+17% +$18M ﹤0.01% 1925
2023
Q4
$97.6M Buy
4,180,507
+203,187
+5% +$4.74M ﹤0.01% 2061
2023
Q3
$201M Buy
3,977,320
+656,167
+20% +$33.2M 0.01% 1536
2023
Q2
$155M Buy
3,321,153
+537,776
+19% +$25.1M ﹤0.01% 1750
2023
Q1
$106M Buy
2,783,377
+24,848
+0.9% +$951K ﹤0.01% 1957
2022
Q4
$151M Buy
2,758,529
+413,052
+18% +$22.6M ﹤0.01% 1717
2022
Q3
$79.9M Buy
2,345,477
+254,236
+12% +$8.66M ﹤0.01% 2093
2022
Q2
$19.8M Buy
2,091,241
+195,713
+10% +$1.85M ﹤0.01% 3027
2022
Q1
$26.9M Sell
1,895,528
-48,594
-2% -$690K ﹤0.01% 2919
2021
Q4
$41.1M Buy
1,944,122
+77,565
+4% +$1.64M ﹤0.01% 2743
2021
Q3
$41.7M Buy
1,866,557
+18,709
+1% +$418K ﹤0.01% 2746
2021
Q2
$45.8M Buy
1,847,848
+383,030
+26% +$9.5M ﹤0.01% 2721
2021
Q1
$42.5M Buy
1,464,818
+117,914
+9% +$3.42M ﹤0.01% 2683
2020
Q4
$34.8M Sell
1,346,904
-6,854
-0.5% -$177K ﹤0.01% 2646
2020
Q3
$41.7M Buy
1,353,758
+323,776
+31% +$9.97M ﹤0.01% 2352
2020
Q2
$25.7M Buy
1,029,982
+309,868
+43% +$7.72M ﹤0.01% 2626
2020
Q1
$15.3M Buy
720,114
+180,215
+33% +$3.82M ﹤0.01% 2705
2019
Q4
$12M Buy
539,899
+232,043
+75% +$5.15M ﹤0.01% 3112
2019
Q3
$7.01M Buy
307,856
+161,694
+111% +$3.68M ﹤0.01% 3343
2019
Q2
$2.8M Buy
+146,162
New +$2.8M ﹤0.01% 3622